RWS (LON:RWS) had its price objective hoisted by stock analysts at Barclays from GBX 560 ($7.32) to GBX 610 ($7.97) in a research report issued on Wednesday, ThisIsMoney.Co.Uk reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential downside of 1.45% from the company’s previous close.
Several other brokerages have also issued reports on RWS. Numis Securities lowered shares of RWS to an “add” rating and boosted their target price for the company from GBX 450 ($5.88) to GBX 600 ($7.84) in a research report on Thursday, June 6th. Berenberg Bank boosted their target price on shares of RWS from GBX 615 ($8.04) to GBX 670 ($8.75) and gave the company a “buy” rating in a research report on Tuesday.
Shares of LON RWS opened at GBX 619 ($8.09) on Wednesday. The company has a debt-to-equity ratio of 29.07, a current ratio of 1.46 and a quick ratio of 1.32. The company has a market cap of $1.70 billion and a P/E ratio of 59.52. RWS has a 12-month low of GBX 379 ($4.95) and a 12-month high of GBX 632 ($8.26).
RWS Holdings plc engages in the translation, intellectual property (IP) support, life sciences language, and localization businesses. The company operates through four segments: Patent Translation & Filing, Patent Information, Life Sciences, and Language Solutions. The Patent Translation & Filing segment undertakes patent translation and filing services of patent activities, as well as IP translations for litigation and information purposes, including prior-art documents, office actions, opposition proceedings and correspondence, and written opinions of international searching authorities.
Recommended Story: What is the Fibonacci sequence?
Receive News & Ratings for RWS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RWS and related companies with MarketBeat.com's FREE daily email newsletter.